VI
PTCT icon

Vestcor Inc’s PTC Therapeutics PTCT Stock Holding History

Vestcor Inc’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Hold
19,488
– – 0.04% 405
2026
Q1 		$1.33M Buy
19,488
+6,471
+50% +$458K 0.04% 423
2025
Q4 		$989K Hold
13,017
– – 0.03% 495
2025
Q3 		$799K Buy
13,017
+8,143
+167% +$424K 0.02% 566
2025
Q2 		$238K Buy
+4,874
New +$231K 0.01% 928

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Vestcor Inc's PTCT Position: Q2 2026 in Review

Vestcor Inc held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 19,488 shares worth $1.59M. The position accounts for 0.04% of the portfolio, ranked #405.

Vestcor Inc first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Vestcor Inc held 19,488 shares of PTC Therapeutics worth $1.59M as of Q2 2026.
  • Vestcor Inc left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up 0.04% of Vestcor Inc's portfolio in Q2 2026, its #405 holding.
  • Vestcor Inc first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.